思勤医疗SEEKIN
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
SeekIn Presents Cost-Effective Two-Step Multi-Cancer Screening Strategy and Breakthrough Lung Cancer Early Detection Test at Early Detection of Cancer Conference in San Francisco 2024-10-24 20:00
SeekIn Presents New OncoSeek® Data at the AACR Annual Meeting in San Diego 2024-04-08 20:00
SeekIn and OncoInv Collaborate to Expand the Global Accessibility of Multiple Cancer Detection Tests and Bridge Global Disparities in Cancer Care 2023-12-15 21:00
SeekIn Presents Retrospective and Prospective Validation Studies of SeekInCare Multi-omics Multi-cancer Early Detection test at the 20th ICGC Workshop and 7th ARGO Meeting in New York 2023-11-10 21:00
SeekIn Presents New Validation Studies of OncoSeek Multi-cancer Early Detection test at Early Detection of Cancer Conference in London 2023-10-16 20:00
SeekIn paves the way for cancer early detection in low- and middle-income countries 2023-06-16 21:00
SeekIn Receives CE-IVD Mark Approval for PanCanSeek® Cancer Mutation Detection Kit 2022-12-19 21:00
SeekIn Receives CE-IVD Mark Approval for SeekInCure® Cancer Recurrence Monitoring Kit 2022-11-28 21:00
SeekIn Demonstrates the Power of Treatment Response Monitoring Test at the Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo 2022-11-07 21:00
SeekIn Presents New Data Supporting its Pan-cancer Early Detection Test at the Early Detection of Cancer Conference 2022 2022-10-19 20:30
SeekIn Receives CE Mark Approval for OncoSeek® Multi-Cancer Detection Test 2022-09-12 21:37
SeekIn Receives CE Mark Approval for SeekInClarity™ Cancer Treatment Response Monitoring Kit 2022-05-25 20:30
SeekIn Receives CE Mark Approval for LeukoPrint® Molecular Karyotyping Test 2022-04-07 22:22
SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer Early Detection Test 2022-02-24 21:34
1